FOXO Technologies Inc.

FOXOW ·Healthcare, Diagnostics & Research, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $4.7M $5.2M $4.4M $3.5M $5.2M $3.2M $2.8M $1.2M
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development $23.7K $35.6K $35.2K $77.1K $40.2K $30.0K $0 $43.8K
SG&A Expense $2.7M $2.9M $3.5M $2.5M $2.6M $2.8M $3.0M $1.7M
Operating Income $8.7M $-276.9K $-8.5M $-859.8K $567.1K $-1.5M $-4.0M $-1.0M
Operating Margin 185.5% -5.4% -191.6% -24.2% 10.9% -48.8% -141.4% -84.0%
Interest Expense $1.3M $973.1K $601.2K $934.2K $1.0M $889.8K $2.4M $956.7K
Pretax Income $8.1M $-1.5M $-9.6M $-1.9M $-526.3K $-620.8K $-6.8M $-2.0M
Income Tax Expense — — — — — — — —
Net Income $8.1M $-1.5M $-9.4M $-1.9M $-522.0K $-616.5K $-6.8M $-1.9M
Net Margin 172.6% -28.1% -212.5% -52.9% -10.0% -19.4% -240.9% -162.7%
EPS (Basic) — — — — — — — —
EPS (Diluted) — — — — — — — —
Shares Outstanding (Basic) — — — — — — — —
Shares Outstanding (Diluted) — — — — — — — —
Dividends Per Share — — — — — — — —
← Newer Page 1 of 3 Older →